Navigation Links
3-V Biosciences Completes $20 Million Series C Financing
Date:6/21/2013

MENLO PARK, Calif., June 21, 2013 /PRNewswire/ -- 3-V Biosciences, Inc., a biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious disease, today announced the completion of a Series C financing round, raising $20 million. Proceeds from the financing will be used to advance 3-V's lead oncology candidate into a Phase 1 clinical trial and to conduct ongoing preclinical studies of multiple virology leads generated by the company's integrated drug discovery process. Existing investors Kleiner Perkins Caufield & Byers and New Enterprise Associates participated in the round.

(Logo: http://photos.prnewswire.com/prnh/20121001/LA83573LOGO)

"I am very pleased by the recognition of our efforts and continued support from our existing investors," said Merdad Parsey, M.D., Ph.D., Chief Executive Officer of 3-V Biosciences. "3-V takes an integrated approach to building its pipeline by applying our proprietary screening methodology combined with our expertise in medicinal chemistry, drug discovery and development to generate proprietary therapeutic candidates that target key pathways in oncology and infectious diseases. Our lead oncology candidate has demonstrated compelling anti-tumor activity in pre-IND studies and with the funds from our Series C, we look forward to advancing into the clinic later this year."

3-V's lead molecule is one of a series of novel fatty acid synthase (FASN) inhibitors initially being developed to treat solid tumor cancers. FASN over-expression is associated with aggressive disease and poor prognosis in a number of cancers. In a series of preclinical studies, 3-V has demonstrated potent activity against multiple tumor types, including lung, breast, prostate and colon cancers. In addition, 3-V has demonstrated potential
'/>"/>

SOURCE 3-V Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 29, 2014 Research and Markets ... Cancer Therapeutics Market & Pipeline Insight 2014" report ... developed to prevent and eradicate the prevalence of cancer ... are confined to low specificity, safety and large number ... for a better solution. It has been discovered that ...
(Date:8/29/2014)... SPRING, Md. , Aug. 29, 2014  United ... that the U.S. District Court for the District of ... its favor in the company,s case against Sandoz, Inc. ... Judge Peter Sheridan ruled that U.S. Patent ... Inc., and enjoined Sandoz from marketing its generic product ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
(Date:8/30/2014)... Atlanta, GA (PRWEB) August 30, 2014 ... US Open Challenge and K.Warrior Search on November 8th, ... Over 20 years, these events have introduced many notorious ... such as Strike-Force, IWF and the UFC. , ... seen numerous fighters leave its doors armed with the ...
(Date:8/30/2014)... 30 August 2014: The first multidisciplinary recommendations on ... coronary syndromes (ACS) are published today in ... written jointly by the European Heart Rhythm Association ... the European Association of Percutaneous Cardiovascular Interventions (EAPCI), ... Gorenek (Turkey), chairperson of the task force, said: ...
(Date:8/30/2014)... Saturday 30 August 2014: The first recommendations on ... pulmonary embolism are published today in new ESC ... by Professor Stavros V. Konstantinides (Germany/Greece) and Professor ... on the diagnosis and management of acute pulmonary ... Journal (1) and on the ESC Website. , ...
(Date:8/29/2014)... Daily Gossip writes in its review that this is ... This method promises to teach readers how to eliminate the ... alternative sources for the production of energy. , Some ... solar power. , The Home Made Energy review indicates ... So, this is an online guide that will teach its ...
(Date:8/29/2014)... (PRWEB) August 30, 2014 Cancer ... loved ones and caretakers. Author Eddie M. Leung knows the ... cholangiocarcinoma or bile duct cancer, a very rare and ... That Changed My Life” (published by Xlibris), he shares a ... importantly, he imparts a survivor’s testimony that this disease can ...
Breaking Medicine News(10 mins):Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 2Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 3Health News:KSF Presents US Open Challenge-K. Warrior Search, Seeking Inspirational Warrior Fighters Like Cung Le 4Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:First recommendations on all new oral anticoagulants in pulmonary embolism published 2Health News:Home Made Energy Review Exposes Simple Method to Access Alternative Energy Sources 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 2Health News:Eddie M. Leung Shares His Testimony As a Survivor of Cancer 3
... may not be at,the top of your list of fun ... makes having any kind of fun a lot harder in ... your fiber intake, while enjoying the,benefits of regularity., Listen ... http://media.medialink.com/WebNR.aspx?story=35262 ., Registered journalists can access video, audio, text, ...
... Ind., June 19 Zimmer Holdings, Inc.,(NYSE: ... that it will partner with AmeriCares,one of ... donations, to support emergency response and ongoing ... at $1 million to,three of AmeriCares, primary ...
... a major international clinical trial coordinated by the Montreal ... England Journal of Medicine . The Atrial Fibrillation and ... project involving patients with heart failure and atrial fibrillation. ... the population and associated atrial fibrillation (a very common ...
... for diarrhea worldwide, study says , , THURSDAY, June 19 (HealthDay ... may help dysentery-causing amoeba evade the immune system. , ... fight dysentery, a form of diarrhea that affects about 500 ... threat in many regions. , "This is the first ...
... June 19 NightHawk,Radiology Holdings, Inc. (Nasdaq: NHWK ... and hospitals throughout the United States,today announced the final ... at 5:00 p.m. Eastern Time on Friday, June 13, ... depositary for the tender offer, an,aggregate of 2,240,883 shares ...
... June 19 Minneapolis-based Courage Center,is pleased to announce ... 2008,Eleven Who Care Agency of Distinction., Over the ... has,recognized the outstanding efforts of 264 (275 including 2008) ... amazing. Since the,awards began, 12 Courage Center volunteers (including ...
Cached Medicine News:Health News:Zimmer Holdings to Partner with AmeriCares for Global Product Donation Program 2Health News:Zimmer Holdings to Partner with AmeriCares for Global Product Donation Program 3Health News:The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation 2Health News:The Montreal Heart Institute presents findings on congestive heart failure and atrial fibrillation 3Health News:Scientists ID Enzyme That Allows Dysentery Amoeba to Hide 2Health News:NightHawk Radiology Holdings, Inc. Announces Final Results of Tender Offer; NightHawk Purchases 2,240,883 Shares of Its Common Stock at $8.05 per Share 2Health News:Courage Center Honored With KARE TV's 2008 Eleven Who Care Agency of Distinction 2
... with brass and aluminum body., ... suffix S to model number. Example: ... suffix C to model number. Example: ... Power Take-Off, add PT to model ...
... FM Series Oxygen Flowmeters with Power ... security chain, add suffix S to ... Canadian Color-Code, add suffix C to ... Double Flowmeters with Power Take-Off, add ...
... proficiency testing solutions with outstanding customer service ... is one of the largest proficiency testing ... laboratories enrolled. Here are just some of ... Paperless Proficiency Testing, Free CME/CMLE Credits ...
... a new functional test which exhibits 100% ... C Resistance caused by the Factor V ... commercially available methods, Pefakit APC-R FVL shows ... Lupus Anticoagulants, Elevated FVIII levels, Heparins or ...
Medicine Products: